Long-Term Safety Analysis of a Fibrinogen Concentrate (RiaSTAP/Haemocomplettan P)
Fibrinogen concentrate treatment is recommended for acute bleeding episodes in adult and pediatric patients with congenital and acquired fibrinogen deficiency. Previous studies have reported a low risk of thromboembolic events (TEEs) with fibrinogen concentrate use; however, the post-treatment TEE r...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publishing
2024-05-01
|
| Серии: | Clinical and Applied Thrombosis/Hemostasis |
| Online-ссылка: | https://doi.org/10.1177/10760296241254106 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|